{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:40:26Z","timestamp":1759452026988,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["08512"],"award-info":[{"award-number":["08512"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.vaccine.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T15:21:35Z","timestamp":1676128895000},"page":"1774-1777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of cross-protection between S. Pneumoniae serotypes 35B and 29 in a mouse model"],"prefix":"10.1016","volume":"41","author":[{"given":"Ellie","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin M.","family":"Kaufhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Nawrocki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2023.02.001_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2016.1277300","article-title":"Pneumococcal serotype distribution: a snapshot of recent data in pediatric and adult populations around the world","volume":"13","author":"Cui","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.02.001_b0010","doi-asserted-by":"crossref","unstructured":"Yeh S. H, Gurtman A, Hurley D. C, Block S. L, Schwartz R. H, Patterson S, Jansen K. U, Love J, Gruber W. C, Emini E. A, Scott D. A, Group, o. b. o. t. S. Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers. Pediatrics, 126 3 2010 e493-e505. https:\/\/doi.org\/10.1542\/peds.2009-3027.","DOI":"10.1542\/peds.2009-3027"},{"issue":"4","key":"10.1016\/j.vaccine.2023.02.001_b0015","doi-asserted-by":"crossref","first-page":"e0125636","DOI":"10.1371\/journal.pone.0125636","article-title":"Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae show high potential for biofilm formation in vitro","volume":"10","author":"Domenech","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.001_b0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013\u201318","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.vaccine.2023.02.001_b0025","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/cid\/cix685","article-title":"Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations","volume":"65","author":"Naucler","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"41","key":"10.1016\/j.vaccine.2023.02.001_b0030","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1016\/j.vaccine.2011.06.056","article-title":"The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A","volume":"29","author":"Cooper","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.02.001_b0035","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/315096","article-title":"Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants","volume":"180","author":"Yu","year":"1999","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.02.001_b0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1086\/317934","article-title":"Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B","volume":"183","author":"Saeland","year":"2001","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2023.02.001_b0045","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/593339","article-title":"Differential effects of pneumococcal vaccines against serotypes 6A and 6C","volume":"198","author":"Park","year":"2008","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2023.02.001_b0050","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1021\/acschembio.1c00347","article-title":"Glycan array evaluation of synthetic epitopes between the capsular polysaccharides from streptococcus pneumoniae 19F and 19A","volume":"16","author":"Morelli","year":"2021","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.vaccine.2023.02.001_b0055","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac154","article-title":"Impact of pneumococcal conjugate vaccines on antibiotic-nonsusceptible invasive pneumococcal disease in the united states","author":"Bajema","year":"2022","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.02.001_b0060","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: past, present, and future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2023.02.001_b0065","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/424596","article-title":"Tissue-specific contributions of pneumococcal virulence factors to pathogenesis","volume":"190","author":"Orihuela","year":"2004","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2023.02.001_b0070","doi-asserted-by":"crossref","first-page":"e1005337","DOI":"10.1371\/journal.ppat.1005337","article-title":"Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia","volume":"11","author":"Gonz\u00e1lez-Juarbe","year":"2015","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.vaccine.2023.02.001_b0075","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/CVI.00014-06","article-title":"Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay","volume":"13","author":"Marchese","year":"2006","journal-title":"Clin vaccine immunol: CVI"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.001_b0080","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.vaccine.2016.12.055","article-title":"Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain","volume":"35","author":"Caro-Aguilar","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.02.001_b0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.vaccine.2021.08.049","article-title":"A phase 3 trial of safety, tolerability, and immunogenicity of V. 114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)","volume":"40","author":"Platt","year":"2022","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2023.02.001_b0090","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/CVI.00112-06","article-title":"Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies","volume":"13","author":"Burton","year":"2006","journal-title":"Clin vaccine immunol CVI"},{"issue":"6","key":"10.1016\/j.vaccine.2023.02.001_b0095","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/CVI.00086-12","article-title":"Development of a fourfold multiplexed opsonophagocytosis assay for pneumococcal antibodies against additional serotypes and discovery of serological subtypes in Streptococcus pneumoniae serotype 20","volume":"19","author":"Burton","year":"2012","journal-title":"Clin vaccine immunol CVI"},{"key":"10.1016\/j.vaccine.2023.02.001_b0100","doi-asserted-by":"crossref","unstructured":"Platt H.L, Omole T, Cardona J.F, Fraser N.J, Mularski R.A, Andrews C, Daboul N, Gallagher N, Sapre A, Li J, Polis A, Fernsler D, Tamms G. M, Xu W, Murphy R, Skinner J. M, Joyce J, Musey L.K. Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: a randomized, double-blind phase \u00bd trial. \u201cin press, Lancet infectious Disease\u201d 2022","DOI":"10.1016\/S1473-3099(22)00526-6"},{"issue":"9","key":"10.1016\/j.vaccine.2023.02.001_b0105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/CVI.00184-07","article-title":"Functional Antibodies to the O-Acetylated Pneumococcal Serotype 15B Capsular Polysaccharide Have Low Cross-Reactivities with Serotype 15C","volume":"14","author":"Rajam","year":"2007","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:23:40Z","timestamp":1759404220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0264410X23001275"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of cross-protection between S. Pneumoniae serotypes 35B and 29 in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}